-Maastricht University The Policy Brief entitled 'The Key to Resolving Straw Burning: Farmers' expertise' was produced under the project Responsible Innovation in Biogas in India, which was funded by the Netherlands Organization of Scientific Research (NWO) and executed at Maastricht University. In the brief, the researchers call for the following policy actions: * Establish comprehensive working groups to engage with issues of straw burning, air pollution, agricultural practices and industries. * Notably, expertise on...

-Press Information Bureau/ Ministry of Finance The Union Minister of Finance and Corporate Affairs Shri Arun Jaitley said that there is a need to conserve water, incentivize agro processing and promote balanced use of fertilizers in order to ensure higher agriculture productivity. The Finance Minister said that in order to achieve the goal of doubling the farmer’s income by 2022, there is need for better storage and marketing facilities for the...

-Livemint.com The regulatory system for the seed and biotech industry should be transparent, science-based, predictable and fair For many decades, the Indian policy framework facilitated the interaction of science and Innovation with entrepreneurship, which led to competition and the subsequent development of an industry structure that delivered sustainable economic benefits. The government was a major contributor to investments in seed research in India for close to three decades after independence. Policy reforms like...

-The Financial Express Every year, the onset of winter in Delhi unfailingly brings to the fore the burning of paddy residue in Punjab and Haryana, given the practice contributes significantly to the national capital’s air pollution woes, with severe consequences for public health. According to an IIT study, 17% of the PM 10 load and 26% of the PM 2.5 load in October-November in Delhi can be attributed to post-monsoon crop...

-Down to Earth Why did we grant Pfizer's claim on a pneumonia vaccine which has been rejected elsewhere? In august, the medical and public health fraternity was stunned when India’s Patent Office granted US pharma giant Pfizer’s claim on its vaccine against pneumonia, the pneumococcal conjugate vaccine (PCV), marketed as Prevnar13. For a country that has stricter patentability criteria than most others, India’s decision was baffling because Pfizer’s patent has been rejected...